Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Jennifer Diamond

Concepts (355)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Triple Negative Breast Neoplasms
16
2024
220
6.000
 Why?
Breast Neoplasms
27
2026
2420
4.170
 Why?
Antineoplastic Agents
23
2023
2231
2.330
 Why?
Immunoconjugates
7
2023
138
2.320
 Why?
Antineoplastic Combined Chemotherapy Protocols
20
2025
2001
2.180
 Why?
Pyrimidines
9
2021
532
2.150
 Why?
Protein Kinase Inhibitors
11
2025
984
1.670
 Why?
Piperazines
5
2023
375
1.570
 Why?
Paclitaxel
6
2022
261
1.460
 Why?
Camptothecin
9
2023
138
1.450
 Why?
Neoplasms
15
2026
2946
1.430
 Why?
Pyrazoles
6
2021
518
1.220
 Why?
Ovarian Neoplasms
5
2025
599
1.210
 Why?
Quinoxalines
2
2020
65
1.200
 Why?
Azepines
3
2020
105
1.130
 Why?
Histone Deacetylase Inhibitors
4
2024
219
1.110
 Why?
Antibodies, Monoclonal, Humanized
10
2024
1005
1.100
 Why?
Cyclin-Dependent Kinase 4
2
2018
53
1.000
 Why?
Cyclin-Dependent Kinase 6
2
2018
49
1.000
 Why?
Carcinoma, Lobular
3
2026
59
0.830
 Why?
Neutropenia
4
2022
154
0.810
 Why?
Benzoxazoles
2
2021
20
0.800
 Why?
Xenograft Model Antitumor Assays
12
2026
939
0.720
 Why?
Gene Expression Regulation, Neoplastic
5
2020
1457
0.720
 Why?
Maximum Tolerated Dose
10
2026
217
0.690
 Why?
Breast Neoplasms, Male
2
2018
29
0.680
 Why?
beta Catenin
2
2020
254
0.680
 Why?
Female
59
2026
80076
0.650
 Why?
Receptors, Estrogen
3
2021
406
0.630
 Why?
Chemotherapy, Adjuvant
4
2023
429
0.630
 Why?
Cancer Care Facilities
1
2020
48
0.620
 Why?
Lymphocytes, Tumor-Infiltrating
2
2020
156
0.620
 Why?
Tumor Microenvironment
5
2026
748
0.600
 Why?
Nuclear Proteins
3
2026
745
0.600
 Why?
eIF-2 Kinase
1
2019
28
0.600
 Why?
Humans
71
2026
147293
0.570
 Why?
Anthracyclines
3
2023
49
0.560
 Why?
Pyridines
5
2025
610
0.550
 Why?
Taxoids
3
2023
116
0.550
 Why?
Aged
27
2026
26514
0.530
 Why?
Aurora Kinase A
4
2020
61
0.520
 Why?
Carcinoma, Ductal, Breast
1
2018
91
0.520
 Why?
Wnt Signaling Pathway
1
2019
212
0.510
 Why?
Drug Resistance, Neoplasm
4
2020
889
0.500
 Why?
Trastuzumab
4
2023
119
0.500
 Why?
Pyrazines
2
2018
94
0.490
 Why?
Aromatase Inhibitors
3
2025
81
0.480
 Why?
Colonic Neoplasms
1
2018
258
0.470
 Why?
Myocardial Infarction
1
2023
1213
0.460
 Why?
Tumor Suppressor Protein p53
4
2024
536
0.460
 Why?
Cell Line, Tumor
11
2026
3565
0.450
 Why?
Angiopoietin-1
1
2015
12
0.450
 Why?
Angiopoietin-2
1
2015
15
0.450
 Why?
Neoadjuvant Therapy
1
2018
474
0.430
 Why?
Neoplasm Recurrence, Local
5
2025
1166
0.430
 Why?
Middle Aged
28
2026
36821
0.400
 Why?
Uterine Cervical Neoplasms
1
2017
268
0.400
 Why?
Medicare
4
2023
915
0.390
 Why?
Bridged-Ring Compounds
2
2023
32
0.390
 Why?
Adult
29
2026
41405
0.380
 Why?
Dose-Response Relationship, Drug
6
2022
2030
0.370
 Why?
Colorectal Neoplasms
5
2022
876
0.370
 Why?
Tumor Suppressor Proteins
1
2015
323
0.370
 Why?
Proto-Oncogene Proteins c-met
1
2013
76
0.370
 Why?
Cell Proliferation
8
2020
2529
0.370
 Why?
Quinolines
4
2025
192
0.360
 Why?
Lung Neoplasms
3
2026
2679
0.360
 Why?
Antibodies, Monoclonal
4
2024
1514
0.360
 Why?
Recombinant Fusion Proteins
1
2015
669
0.360
 Why?
Radiosurgery
3
2025
400
0.360
 Why?
Point Mutation
1
2013
245
0.360
 Why?
Antineoplastic Agents, Immunological
3
2019
200
0.360
 Why?
Treatment Outcome
13
2025
11947
0.350
 Why?
Neoplasm Metastasis
5
2026
695
0.350
 Why?
Triazoles
1
2013
191
0.340
 Why?
Angiogenesis Inhibitors
3
2018
239
0.340
 Why?
Mice, Nude
6
2020
680
0.330
 Why?
Clinical Trials, Phase I as Topic
2
2020
50
0.320
 Why?
Carcinoma, Renal Cell
1
2013
233
0.320
 Why?
Aged, 80 and over
10
2025
8430
0.320
 Why?
Mitochondria
1
2017
1000
0.310
 Why?
Heart Failure
1
2023
2334
0.310
 Why?
Histones
3
2023
672
0.310
 Why?
Genes, BRCA2
1
2009
33
0.300
 Why?
Adaptor Proteins, Signal Transducing
2
2026
430
0.300
 Why?
Genes, BRCA1
1
2009
45
0.300
 Why?
Molecular Targeted Therapy
3
2019
444
0.290
 Why?
Biomarkers, Tumor
2
2014
1339
0.290
 Why?
BRCA2 Protein
1
2009
68
0.290
 Why?
Apoptosis
7
2024
2454
0.290
 Why?
Pregnancy Complications, Neoplastic
1
2009
64
0.280
 Why?
Thrombophilia
1
2009
89
0.280
 Why?
Neoplasm Staging
5
2021
1492
0.280
 Why?
Kidney Neoplasms
1
2013
421
0.280
 Why?
Mice
12
2026
18491
0.280
 Why?
Receptors, Progesterone
2
2021
244
0.270
 Why?
Poly(ADP-ribose) Polymerase Inhibitors
2
2026
137
0.270
 Why?
Adenine
2
2021
339
0.270
 Why?
DNA-Binding Proteins
1
2015
1488
0.260
 Why?
Aminopyridines
3
2026
129
0.240
 Why?
Models, Biological
1
2014
1772
0.240
 Why?
Nicotinamide Phosphoribosyltransferase
1
2026
26
0.240
 Why?
Cell Cycle Proteins
3
2026
633
0.230
 Why?
Selective Estrogen Receptor Modulators
1
2025
34
0.220
 Why?
Doxorubicin
3
2024
411
0.220
 Why?
Cardiorespiratory Fitness
1
2025
75
0.220
 Why?
Professional-Family Relations
1
2026
159
0.220
 Why?
Neuroblastoma
1
2026
177
0.210
 Why?
Animals
15
2026
38410
0.210
 Why?
Biopsy
3
2018
1093
0.210
 Why?
Cyclophosphamide
2
2018
277
0.200
 Why?
DNA Repair
1
2026
256
0.200
 Why?
Trans-Activators
1
2026
398
0.200
 Why?
Wound Healing
1
2026
361
0.190
 Why?
Disease Models, Animal
3
2021
4604
0.190
 Why?
Brain Neoplasms
3
2025
1338
0.180
 Why?
Liver Neoplasms
1
2009
787
0.180
 Why?
United States
5
2023
16313
0.180
 Why?
Cyclin-Dependent Kinase 9
1
2022
18
0.180
 Why?
Histone Deacetylase 1
1
2022
23
0.180
 Why?
Aurora Kinases
2
2012
28
0.180
 Why?
G2 Phase Cell Cycle Checkpoints
3
2022
44
0.180
 Why?
Topoisomerase I Inhibitors
2
2022
20
0.170
 Why?
Fluorouracil
1
2022
232
0.170
 Why?
Administration, Oral
3
2022
874
0.170
 Why?
Disease Progression
4
2019
2890
0.170
 Why?
Acetylation
1
2022
262
0.170
 Why?
Androstadienes
1
2021
77
0.160
 Why?
Biliary Tract Neoplasms
1
2021
31
0.160
 Why?
Arrhythmias, Cardiac
1
2023
360
0.160
 Why?
Heterografts
1
2021
143
0.160
 Why?
Drug Administration Schedule
3
2017
789
0.160
 Why?
Diarrhea
2
2019
193
0.160
 Why?
Hospitals, University
1
2021
176
0.160
 Why?
Carboplatin
1
2021
168
0.160
 Why?
Necrosis
2
2019
245
0.160
 Why?
Histone Deacetylases
1
2022
208
0.160
 Why?
Male
16
2026
73950
0.160
 Why?
Mechanistic Target of Rapamycin Complex 2
1
2020
62
0.150
 Why?
Fatigue
2
2022
367
0.150
 Why?
Cancer Survivors
1
2025
347
0.150
 Why?
Immune System
1
2021
181
0.150
 Why?
Immunotherapy
2
2023
672
0.150
 Why?
Myeloid Cell Leukemia Sequence 1 Protein
1
2019
39
0.150
 Why?
Clinical Trials as Topic
3
2016
1072
0.150
 Why?
Benzodiazepines
1
2021
169
0.150
 Why?
Mechanistic Target of Rapamycin Complex 1
1
2020
138
0.150
 Why?
Corneal Ulcer
1
1999
21
0.150
 Why?
Kaplan-Meier Estimate
1
2021
975
0.140
 Why?
Tumor Cells, Cultured
1
2020
891
0.140
 Why?
Albumins
1
2019
119
0.140
 Why?
Aquaporin 4
1
2019
102
0.140
 Why?
Maintenance Chemotherapy
1
2018
42
0.140
 Why?
Sucrase
1
1998
2
0.140
 Why?
Vascular Endothelial Growth Factor A
2
2018
552
0.130
 Why?
Microvilli
1
1998
75
0.130
 Why?
Cytokines
1
2026
2086
0.130
 Why?
Nausea
1
2018
112
0.130
 Why?
Cornea
1
1999
156
0.130
 Why?
Mice, Inbred BALB C
1
2020
1266
0.130
 Why?
Drug Therapy, Combination
1
2020
1046
0.130
 Why?
Breast
1
2018
157
0.130
 Why?
Antibodies, Bispecific
1
2018
69
0.130
 Why?
Radiotherapy, Adjuvant
1
2018
222
0.130
 Why?
Purines
1
2018
188
0.130
 Why?
Benzimidazoles
1
2018
190
0.130
 Why?
Topotecan
1
2017
17
0.130
 Why?
Isoflavones
1
2017
25
0.130
 Why?
Bacterial Infections
1
1999
247
0.130
 Why?
Caregivers
1
2026
1091
0.130
 Why?
Imidazoles
1
2018
247
0.130
 Why?
Calcium-Binding Proteins
1
2018
222
0.130
 Why?
Carbolines
1
2017
35
0.120
 Why?
Heterocyclic Compounds, 4 or More Rings
1
2017
24
0.120
 Why?
Survival Analysis
1
2020
1386
0.120
 Why?
Inhibitory Concentration 50
2
2016
91
0.120
 Why?
Programmed Cell Death 1 Receptor
1
2019
268
0.120
 Why?
Mastectomy
1
2018
188
0.120
 Why?
Hypertension
2
2018
1280
0.120
 Why?
Cell Survival
1
2019
1111
0.120
 Why?
Insulin-Like Growth Factor I
1
2018
318
0.120
 Why?
Neoplasms, Radiation-Induced
1
2016
100
0.120
 Why?
GPI-Linked Proteins
1
2016
81
0.110
 Why?
Retrospective Studies
4
2025
17560
0.110
 Why?
Neoplasms, Second Primary
1
2016
103
0.110
 Why?
Tumor Protein p73
1
2015
18
0.110
 Why?
Antibodies, Neoplasm
1
2015
34
0.110
 Why?
Phosphorylation
1
2019
1721
0.110
 Why?
Risk Reduction Behavior
1
2016
221
0.110
 Why?
Carcinoma, Non-Small-Cell Lung
1
2024
1195
0.110
 Why?
Hodgkin Disease
1
2016
173
0.110
 Why?
Oxazoles
2
2025
48
0.110
 Why?
Maytansine
1
2014
18
0.100
 Why?
Nanoparticles
1
2021
524
0.100
 Why?
Demography
1
2015
283
0.100
 Why?
Brain Edema
1
2014
63
0.100
 Why?
Protein Kinases
1
2015
312
0.100
 Why?
Drug Interactions
1
2015
405
0.100
 Why?
Bacteria
1
1999
769
0.100
 Why?
Threonine
1
2013
44
0.100
 Why?
Survival Rate
2
2019
2110
0.100
 Why?
Sulfones
1
2014
127
0.100
 Why?
Exercise
1
2025
2219
0.100
 Why?
Tumor Stem Cell Assay
1
2012
34
0.090
 Why?
Quinazolines
2
2025
266
0.090
 Why?
Drug Evaluation, Preclinical
1
2013
196
0.090
 Why?
Glycine
1
2014
186
0.090
 Why?
Randomized Controlled Trials as Topic
1
2019
1776
0.090
 Why?
Diabetes Mellitus, Type 2
2
2025
2627
0.090
 Why?
Drug Design
1
2013
177
0.090
 Why?
Methionine
1
2013
161
0.090
 Why?
Time Factors
2
2020
7173
0.090
 Why?
Heterozygote
1
2013
317
0.090
 Why?
Intestinal Mucosa
1
1998
676
0.090
 Why?
Treatment Failure
1
2013
360
0.090
 Why?
In Situ Hybridization, Fluorescence
1
2013
330
0.090
 Why?
Disease-Free Survival
1
2014
779
0.090
 Why?
Analgesics, Opioid
1
2021
1167
0.090
 Why?
Neovascularization, Pathologic
1
2013
287
0.090
 Why?
Cell Transformation, Neoplastic
1
2013
340
0.080
 Why?
Receptor Protein-Tyrosine Kinases
1
2013
231
0.080
 Why?
Cluster Analysis
1
2012
502
0.080
 Why?
Carcinoma in Situ
1
2011
46
0.080
 Why?
Computational Biology
1
2015
677
0.080
 Why?
Risk Assessment
1
2020
3784
0.080
 Why?
Vascular Endothelial Growth Factor Receptor-2
1
2010
87
0.080
 Why?
Risk Factors
2
2025
11017
0.080
 Why?
Colorado
1
2020
4591
0.080
 Why?
Sequence Analysis, DNA
1
2013
780
0.080
 Why?
Cellular Senescence
1
2012
229
0.080
 Why?
Mutation
2
2012
4130
0.080
 Why?
Gastric Emptying
1
2009
36
0.070
 Why?
Tumor Burden
1
2010
327
0.070
 Why?
Keratinocytes
1
2010
249
0.070
 Why?
Pregnancy Trimester, Second
1
2009
91
0.070
 Why?
Enteric Nervous System
1
2009
26
0.070
 Why?
Stomach
1
2009
111
0.070
 Why?
Mastectomy, Segmental
1
2009
107
0.070
 Why?
Pregnancy Trimester, First
1
2009
139
0.070
 Why?
Apoptosis Regulatory Proteins
1
2009
187
0.070
 Why?
Muscle, Smooth
1
2009
153
0.070
 Why?
Lymph Node Excision
1
2009
173
0.070
 Why?
Diabetes Mellitus, Experimental
1
2009
199
0.070
 Why?
Risk
1
2009
927
0.060
 Why?
Cell Adhesion Molecules
2
2019
182
0.060
 Why?
Infusions, Intravenous
2
2019
430
0.060
 Why?
Pentosyltransferases
1
2026
7
0.060
 Why?
Cyclic Nucleotide Phosphodiesterases, Type 4
1
2026
15
0.060
 Why?
Antigens, Neoplasm
2
2019
273
0.060
 Why?
Phosphodiesterase 4 Inhibitors
1
2026
12
0.060
 Why?
Cyclopropanes
1
2026
84
0.060
 Why?
Prognosis
2
2018
4383
0.060
 Why?
Acrylamides
1
2026
74
0.060
 Why?
Gene Expression Profiling
1
2012
1794
0.060
 Why?
Phthalazines
1
2026
63
0.060
 Why?
Cyclic AMP Response Element-Binding Protein
1
2026
146
0.060
 Why?
CD8-Positive T-Lymphocytes
2
2023
932
0.050
 Why?
Alveolar Epithelial Cells
1
2026
121
0.050
 Why?
Benzamides
1
2026
227
0.050
 Why?
Accelerometry
1
2025
126
0.050
 Why?
Cell Cycle
2
2018
600
0.050
 Why?
Combined Modality Therapy
2
2019
1281
0.050
 Why?
Mesylates
1
2022
7
0.050
 Why?
Ataxia Telangiectasia Mutated Proteins
1
2022
69
0.050
 Why?
Follow-Up Studies
2
2025
5476
0.050
 Why?
Signal Transduction
2
2014
5272
0.050
 Why?
Oxygen Consumption
1
2025
721
0.050
 Why?
Clinical Protocols
1
2023
284
0.040
 Why?
Ligands
1
2024
675
0.040
 Why?
RNA, Small Interfering
1
2024
643
0.040
 Why?
Chimerism
1
2021
35
0.040
 Why?
Lymphocyte Subsets
1
2021
78
0.040
 Why?
Lymphoid Tissue
1
2021
81
0.040
 Why?
Blood Glucose
3
2025
2359
0.040
 Why?
Liver
1
2009
1916
0.040
 Why?
Mice, SCID
1
2021
369
0.040
 Why?
Hormones
1
2020
136
0.040
 Why?
SEER Program
1
2021
232
0.040
 Why?
Communication
1
2026
989
0.040
 Why?
Mice, Inbred NOD
1
2021
616
0.040
 Why?
Bacteriological Techniques
1
1999
66
0.040
 Why?
Immunohistochemistry
2
2016
1730
0.040
 Why?
M Phase Cell Cycle Checkpoints
1
2018
23
0.040
 Why?
Monosaccharide Transport Proteins
1
1998
56
0.030
 Why?
Tissue Distribution
1
2018
335
0.030
 Why?
Infant, Newborn
1
2009
6543
0.030
 Why?
Anemia
1
2019
192
0.030
 Why?
Insulin Resistance
1
2025
1253
0.030
 Why?
Intestine, Small
1
1998
168
0.030
 Why?
Biological Transport
1
1998
425
0.030
 Why?
In Vitro Techniques
1
1998
1049
0.030
 Why?
Pregnancy
1
2009
7274
0.030
 Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2016
106
0.030
 Why?
Cetuximab
1
2016
111
0.030
 Why?
Neoplasm Transplantation
1
2016
246
0.030
 Why?
Retreatment
1
2016
80
0.030
 Why?
Drug Screening Assays, Antitumor
1
2016
194
0.030
 Why?
Platinum
1
2016
48
0.030
 Why?
Carotid Artery Diseases
1
1996
70
0.030
 Why?
Arterial Occlusive Diseases
1
1996
90
0.030
 Why?
Proto-Oncogene Proteins p21(ras)
1
2016
256
0.030
 Why?
History, Ancient
1
2015
54
0.030
 Why?
Transcription Factors
1
2023
1747
0.030
 Why?
C-Peptide
1
1996
191
0.030
 Why?
Hematopoietic Stem Cell Transplantation
1
2021
703
0.030
 Why?
Carotid Arteries
1
1996
208
0.030
 Why?
Femoral Artery
1
1996
190
0.030
 Why?
Kinetics
1
1998
1569
0.030
 Why?
Databases, Genetic
1
2015
240
0.030
 Why?
Diabetic Angiopathies
1
1996
267
0.030
 Why?
DNA Damage
1
2017
440
0.030
 Why?
Biomarkers
2
2016
4351
0.030
 Why?
Mice, Knockout
1
2021
3153
0.020
 Why?
Cross-Sectional Studies
1
2025
6011
0.020
 Why?
Quality of Life
1
2025
3246
0.020
 Why?
Glucose
1
1998
1051
0.020
 Why?
Phenotype
1
2021
3216
0.020
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2015
267
0.020
 Why?
Tomography, X-Ray Computed
2
2016
2791
0.020
 Why?
Opioid-Related Disorders
1
2021
617
0.020
 Why?
Drug Combinations
1
2013
399
0.020
 Why?
Intracellular Signaling Peptides and Proteins
1
2015
459
0.020
 Why?
Biopsy, Needle
1
2011
186
0.020
 Why?
Lipids
1
1996
723
0.020
 Why?
Proto-Oncogene Proteins
1
2014
627
0.020
 Why?
HT29 Cells
1
2010
37
0.020
 Why?
Enzyme Inhibitors
1
2014
822
0.020
 Why?
Transcription, Genetic
1
2017
1456
0.020
 Why?
Protein-Tyrosine Kinases
1
2013
432
0.020
 Why?
Cohort Studies
1
2021
6099
0.020
 Why?
ErbB Receptors
1
2013
638
0.020
 Why?
Ki-67 Antigen
1
2010
120
0.020
 Why?
Capillary Permeability
1
2010
132
0.020
 Why?
Gastrointestinal Motility
1
2009
29
0.020
 Why?
Biological Clocks
1
2009
48
0.020
 Why?
Patient Selection
1
2013
746
0.020
 Why?
Patient Satisfaction
1
2013
718
0.020
 Why?
Tomography, Emission-Computed, Single-Photon
1
2009
104
0.020
 Why?
Microscopy, Electron
1
2009
417
0.020
 Why?
Membrane Proteins
1
2015
1171
0.020
 Why?
Positron-Emission Tomography
1
2010
344
0.020
 Why?
Rats, Wistar
1
2009
450
0.020
 Why?
Algorithms
1
2015
1868
0.020
 Why?
Magnetic Resonance Imaging
1
2019
3980
0.010
 Why?
Insulin
1
1996
2526
0.010
 Why?
Adolescent
1
2024
22825
0.010
 Why?
Brain
1
2014
3009
0.010
 Why?
Rats
1
2009
5613
0.010
 Why?
Young Adult
1
2014
14437
0.010
 Why?
Tunica Media
1
1996
38
0.010
 Why?
Cholesterol, HDL
1
1996
202
0.010
 Why?
Fasting
1
1996
280
0.010
 Why?
Cholesterol
1
1996
410
0.010
 Why?
Regression Analysis
1
1996
1003
0.010
 Why?
Ultrasonography
1
1996
795
0.010
 Why?
Diamond's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (355) concept(s)
_
Co-Authors Expand Description
See all (74) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)